Evidence map›Paper›PMID 15912040›Full record

ArticleAnnals of surgery2005

Analysis of long-term outcomes of 3200 liver transplantations over two decades: a single-center experience.

Ronald W Busuttil, Douglas G Farmer, Hasan Yersiz, Jonathan R Hiatt, Sue V McDiarmid, Leonard I Goldstein, Sammy Saab, Steven Han, Francisco Durazo, Michael Weaver and 8 more

Open access · greenAbstract read
In one paragraph

Article in Annals of surgery, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 95 papers.

0numbers the graph read from it
0cells of the map it votes in
95citing papers in PubMed
26.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

95 citing papers in PubMed, 405 citations in OpenAlex.

  1. Trial
  2. Posttransplant muscle mass measured by urinary creatinine excretion rate predicts long-term outcomes after liver transplantation.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2019
    Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Key challenges of post-liver transplant weight management.World journal of transplantation · 2024
    Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. LIVER RETRANSPLANTATION: PROGNOSTIC SCORES AND RESULTS IN THE STATE OF PARANÁ.Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery · 2024
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Outcomes of Adult Liver Retransplantation: A Canadian National Database Analysis.Canadian journal of gastroenterology & hepatology · 2022
    Article

35 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 1 institution in 1 country.

Ronald W BusuttilDumont-UCLA Liver Transplant Center, Department of Surgery, David Geffen School of Medicine at UCLA, Los Angeles, California 90095, USA. rghobria@mednet.ucla.edu
Douglas G Farmer
Hasan Yersiz
Jonathan R Hiatt
Sue V McDiarmid
Leonard I Goldstein
Sammy Saab
Steven Han
Francisco Durazo
Michael Weaver
Carlos Cao
Tony Chen
Gerald S Lipshutz
Curtis Holt
Sherilyn Gordon
Jeffery Gornbein
Farin Amersi
Rafik M Ghobrial
UCLA Health · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveFew studies have evaluated long-term outcomes after orthotopic liver transplantation (OLT). This work analyzes the experience of nearly 2 decades by the same team in a single center. Outcomes of OLT and factors affecting survival were analyzed.

methodsRetrospective analysis of 3200 consecutive OLTs that were performed at our institution, between February 1984 and December 31, 2001.

resultsOf 2662 recipients, 578 (21.7%) and 659 (24.7%) were pediatric and urgent patients, respectively. Overall 1-, 5-, 10-, and 15-year patient and graft survival estimates were 81%, 72%, 68%, 64% and 73%, 64%, 59%, 55%, respectively. Patient survival significantly improved in the second (1992-2001) versus the era I (1984-1991) of transplantation (P < 0.001). Similarly, graft survival was better in the era II of transplantation (P < 0.02). However, biliary and infectious complications increased in era II. When OLT indications were considered, best recipient survival was obtained in children with biliary atresia (82%, 79%, and 78% at 1, 5, and 10 years, respectively), while malignant disease in adult patients resulted in the worst outcomes of 68% and 43% at 1 and 5 years, post-OLT. Further, patients <18 years and nonurgent recipients exhibited superior survival when compared with recipients >18 years (P < 0.001) or urgent patients (P < 0.001). Of 13 donor and recipient variables, era of OLT, recipient age, urgent status, donor age, donor length of hospital stay, etiology of liver disease, retransplantation, warm and cold ischemia, but not graft type (whole, split, living-donor), significantly impacted patient survival.

conclusionsLong-term benefits of OLT are greatest in pediatric and nonurgent patients. Multiple factors involving the recipient, etiology of liver disease, donor characteristics, operative variables, and surgical experience influence long-term survival outcomes. By balancing and matching these factors with a given recipient, optimum results can be achieved.

Indexed as

Liver TransplantationAdolescentAdultCarcinoma, HepatocellularChildChild, PreschoolFemaleHumansInfantLiver DiseasesLiver NeoplasmsMaleMiddle AgedMultivariate AnalysisReoperationRetrospective Studies

Identifiers

PMID15912040
PMCPMC1357170
OpenAlexW1992470444

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.